Cemic /Id# 169182

Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires 1431

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies — Completed